KEAP1 was also reported to target NRF2/S100P (S100 calcium-binding protein P) pathway in non-small cell lung cancer (NSCLC) cells, acting as a tumor suppressor. The gene discussed is KEAP1; the disease is non-small cell lung carcinoma.